We are live on
!
Find out more
ST
Sabal Trust Portfolio holdings
AUM
$1.8B
1-Year Est. Return
8.75%
This Fund
S&P 500
This Quarter
Est. Return
+7.74%
1 Year Est. Return
+8.75%
3 Year Est. Return
+18.39%
5 Year Est. Return
+89.81%
10 Year Est. Return
+162.48%
AUM
$767M
AUM Growth
+$51.1M
(+7.1%)
Cap. Flow
+$636K
Cap. Flow
% of AUM
0.08%
Top 10 Holdings %
Top 10 Hldgs %
33.33%
Holding
129
New
26
Increased
36
Reduced
31
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lockheed Martin
LMT
|
+$23.1M |
| 2 |
Merck
MRK
|
+$18.6M |
| 3 |
3M
MMM
|
+$18.3M |
| 4 |
ExxonMobil
XOM
|
+$17.7M |
| 5 |
Amgen
AMGN
|
+$12.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$23.6M |
| 2 |
Unilever
UL
|
+$22.9M |
| 3 |
AbbVie
ABBV
|
+$20.1M |
| 4 |
Novartis
NVS
|
+$19.9M |
| 5 |
Enbridge
ENB
|
+$15.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 17.54% |
| 2 | Industrials | 15.17% |
| 3 | Technology | 10.54% |
| 4 | Healthcare | 10.45% |
| 5 | Financials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
126
Enbridge
ENB
$121B
| – | – |
-429,033
| Closed | -$15.9M |
|
127
Invesco QQQ Trust
QQQ
$449B
| – | – |
-2,085
| Closed | -$212K |
|
128
State Street Technology Select Sector SPDR ETF
XLK
$114B
| – | – |
-206,394
| Closed | -$4.08M |
|
|
AET
129
DELISTED
Aetna Inc
AET
| – | – |
-12,000
| Closed | -$1.31M |
|
Similar funds
FP
UH
PAME
TW
AP
MBA
CC
SSB
Sabal Trust's Q4 2015 Portfolio in Review
As of Q4 2015, Sabal Trust held 129 positions worth $767M, up 7.1% from $716M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Sabal Trust's Q4 2015 filing shows 26 new, 36 increased, 31 reduced and 7 closed positions. Its largest new stake was Lockheed Martin: 106,260 shares worth $23.1M. The largest sale was Du Pont De Nemours E I, an estimated $23.6M.
By sector, the portfolio is most concentrated in Consumer Staples at 18% of assets, down from 20% a quarter earlier, followed by Industrials and Technology.
- Sabal Trust's largest Q4 2015 buy was Lockheed Martin: 106,260 shares worth $23.1M.
- Sabal Trust added most to Merck in Q4 2015, an estimated $18.6M increase.
- Sabal Trust's biggest Q4 2015 reduction was Du Pont De Nemours E I, cutting an estimated $23.6M.
- Sabal Trust fully exited AbbVie in Q4 2015, selling an estimated $20.1M.
- Sabal Trust's ten largest holdings make up 33% of its $767M portfolio in Q4 2015.
- Sabal Trust opened 26 new positions and closed 7 in Q4 2015.
- Sabal Trust's portfolio value rose 7.1% quarter-over-quarter to $767M.
Based on Sabal Trust's 13F filing for Q4 2015, filed 26 Jan 2016.